101
Participants
Start Date
January 31, 2005
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Fentanyl
Fentanyl 1mcg/kg, Intravenous (IV)
Fentanyl
Fentanyl 2mcg/kg, Intravenous (IV)
Dexmedetomidine
Dexmedetomidine, 2mcg/kg, Intravenous (IV)
Dexmedetomidine
Dexmedetomidine, 4mcg/kg Intravenous (IV)
Children's National Medical Center, Washington D.C.
Lead Sponsor
Hospira, now a wholly owned subsidiary of Pfizer
INDUSTRY
Children's National Research Institute
OTHER